UST, uronyl 2-sulfotransferase, 10090

N. diseases: 17; N. variants: 6
Disease: Crohn Disease ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0010346
Disease: Crohn Disease
Crohn Disease 		0.040 Biomarker disease BEFREE Ustekinumab [UST] was recently approved in Europe for the treatment of moderate to severe Crohn's disease [CD]. 30989232 2019
CUI: C0010346
Disease: Crohn Disease
Crohn Disease 		0.040 Biomarker disease BEFREE A systematic review of the available RWE studies of UST for CD and pooled analysis of the available effectiveness and safety data was performed. 31202609 2019
CUI: C0010346
Disease: Crohn Disease
Crohn Disease 		0.040 Biomarker disease BEFREE Ustekinumab [UST] therapy during pregnancy has not yet been extensively evaluated in patients with Crohn's disease. 30388211 2019
CUI: C0010346
Disease: Crohn Disease
Crohn Disease 		0.040 Biomarker disease BEFREE Ustekinumab [UST] is effective in the treatment of adults with moderate to severe Crohn's disease [CD]. 30541021 2019